Latest Breaking News On - Patient global impression - Page 1 : comparemela.com

Sublingual Drug Candidate Improves Sleep Quality in Long COVID

Sublingual Drug Candidate Improves Sleep Quality in Long COVID
sleepreviewmag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sleepreviewmag.com Daily Mail and Mail on Sunday newspapers.

United statesSeth ledermanTonix pharmaceuticals holding corpTonix pharmaceuticalsAmerican society of clinical psychopharmacologyDrug administrationAmerican societyClinical psychopharmacologyPharmaceuticals holding corpPatient global impressionInsomnia severity indexSheehan disability scaleNew drug applicationAcute stress reaction

Endoscopic, histologic improvements in EoE sustained at 52 weeks with etrasimod

WASHINGTON — Once-daily etrasimod 1 mg and 2 mg was well-tolerated and sustained improvements in histological and endoscopic features of eosinophilic esophagitis, as well as patient symptoms, through 52 weeks of treatment, according to data. “Etrasimod is a an oral, once-daily selective sphingosine 1-phosphate receptor modulator for the treatment of moderately to severely active

United statesBykate burbaEvans dellonHeather bieleUniversity of north carolina school medicineEsophageal diseasesNorth carolina schoolDigestive diseaseDigestive disease weekEoe histology scoring systemEoe endoscopic reference scorePatient global impressionDysphagia symptom questionnaire

Inhaled Amikacin Shows Promise for Untreated MAC Lung Infections

ARISE lays the ground work for registrational trial of Arikayce in earlier treatment setting

New yorkUnited statesNational jewish healthCharles daleySarah taimurIcahn school of medicine at mount sinaiAmerican thoracic societyUniversity of colorado school medicineLife bronchiectasis respiratory domainColorado schoolPatient global impressionLikert scaleIcahn schoolMount sinaiNew york cityPatient reported outcome measures

Central Lateral Thalamotomy Improves Outcomes in Severe TN

Preliminary findings suggest lateral thalamotomy results in improved outcomes for patients with refractory trigeminal neuralgia.

United statesAbdul kareem ahmedMary heinricherAmerican association of neurological surgeonsBarrow neurological instituteOregon healthDepartment of neurological surgeryScience university school of medicineUniversity of maryland school medicineMaryland schoolAmerican associationNeurological surgeonsYoung investigatorBrief pain inventoryPain disability indexNumeric rating scale

Late-Breaking Data From Clinical Trials Show Promise for the Future of COPD Treatment

Study authors shared late-breaking data in a session on clinical trial results in pulmonary medicine at the American Thoracic Society 2024 International Conference.

National jewish healthUnited statesSouth koreaCharlesl daleyDave singhSurya bhattUniversity of alabama at birminghamUniversity of manchesterDivision of pulmonaryAmerican thoracic societyManchester universityInternational conferenceUniversity of colorado school medicineClinical trial resultsImage creditHighlights efficacy